Adam Feuerstein, Allison DeAngelis, and Elaine Chen

BioTech

How a Trump presidency could affect the FDA, the biotech industry, and its stocks

Is less regulation by the Food and Drug Administration good for the biotech industry? Do vaccine makers like Pfizer have a target on their back

Adam Feuerstein, Allison DeAngelis, and Elaine Chen November 7, 2024

BioTech

Biden’s health care AI czar, a new obesity company, and its dealmaking CEO

Who is President Biden’s health care AI czar? What does he do? And why do some folks believe he has one of the toughest jobs

Adam Feuerstein, Allison DeAngelis, and Elaine Chen October 3, 2024

BioTech

A new threat to Merck’s blockbuster cancer treatment, Moderna’s cutbacks, and obesity drugs for kids

What’s next for Akeso and Summit Therapeutics after their cancer immunotherapy outperformed Merck’s Keytruda in a large Phase 3 clinical trial? Who’s the iconoclastic outsider

Adam Feuerstein, Allison DeAngelis, and Elaine Chen September 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

Adam Feuerstein, Allison DeAngelis, and Elaine Chen

How a Trump presidency could affect the FDA, the biotech industry, and its stocks

Biden’s health care AI czar, a new obesity company, and its dealmaking CEO

A new threat to Merck’s blockbuster cancer treatment, Moderna’s cutbacks, and obesity drugs for kids

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe